April 19: Leading psychedelics investment conference lands in Miami hosted by Benzinga

The inaugural Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, will take place on April 19, 2022 in Miami, Florida at the Fontainebleau Miami Beach.

Enjoy exclusive curated networking opportunities and unprecedented access to private dealflow at an event hosted by Benzinga, a financial news and data company recently acquired at a valuation of $300 million.

Join Benzinga for a day of unique networking opportunities, exclusive industry insights, and a chance to be in the room with the leaders taking psychedelics to the next level.

Photo by Merlin Lightpainting by Pexels

The Speakers

The Benzinga Psychedelics Capital Conference will feature an array of the brightest minds in the psychedelics field.

Keynote speakers will include Kevin O’Leary, Chairman of O’Shares Investment Advisers and host of ABC’s Shark Tank, and Klee Irwin, CEO of natural products giant Irwin Naturals.

Also present at the conference:

• Tim Schlidt, co-founder and partner of Palo Santo
• Rob Barrow, CEO of MindMed
• Dustin Robison, Managing Partner of Iter Investments
• Lindsay Hoover, Partner of the JLS Fund
• dr Joseph Tucker, CEO of Enveric Biosciences
• Natalie Ginsberg, MAPS Global Impact Officer

“We are excited to welcome the burgeoning psychedelics industry to Benzinga’s growing events ecosystem. We have seen cannabis companies raise hundreds of millions of dollars at our Cannabis Capital Conferences and we are pleased to open this opportunity for companies working to develop and mainstream psychedelics as a new paradigm shift in mental health treatment said Chief Zinger Jason Raznick.

Click here to register for the full in-person Benzinga Psychedelics Capital Conference featuring networking, one-on-ones, investor access and more.

Secure your seat now and get full access to the Benzinga Cannabis Capital Conference taking place April 20-21, 2022 at Fontainebleau Miami Beach. Dual event passes are available.

Why should you attend the Benzinga Psychedelics Capital Conference?

The inaugural Benzinga Psychedelics Capital Conference is a natural offshoot of the now classic Benzinga Cannabis Capital Conferences, which have already featured numerous panels and presentations from key figures in the psychedelics space, including executives from:

• MindMed (NASDAQ:MNMD)
• Enveric Biosciences (NASDAQ:ENVB)
• Mydecin (NEO:MYCO)(OTCPINK:MYCOF)
• Novamind (CSE:NM)(OTCQB:NVMDF)
• Numinus Wellness (TSX:NUMI)(OTCQX:NUMIF)
• NeonMind Biosciences (CSE:NEON) (OTCQB:NMDBF)
• Entheon Biomedical (CSE:ENBI) (OTCQB:ENTBF)
• Cybin (NYSE: CYBN)

After 13 highly successful cannabis editions in Toronto, Chicago, Detroit, New York and Miami, the Benzinga Psychedelics Capital Conference features all the core components of a classic Benzinga event, including keynote addresses, panel discussions, fireside chats, networking rooms, company presentations, and appearances by investors and celebrities.

“Benzinga has always had a strong interest in emerging industries and we believe psychedelics is another sector waiting to grow. We are excited to welcome the executives, investors and analysts at the forefront of this exciting industry to Miami on April 19th. We are even more excited to offer our audience the platform to connect directly with these leaders,” commented Patrick Lane, Benzinga’s executive vice president of partnerships.